These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22524450)

  • 21. Flexibility and inhibitor binding in cdc25 phosphatases.
    Arantes GM
    Proteins; 2010 Nov; 78(14):3017-32. PubMed ID: 20740493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3D QSAR Pharmacophore Based Virtual Screening for Identification of Potential Inhibitors for CDC25B.
    Ma Y; Li HL; Chen XB; Jin WY; Zhou H; Ma Y; Wang RL
    Comput Biol Chem; 2018 Apr; 73():1-12. PubMed ID: 29413811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligand-based chemoinformatic discovery of a novel small molecule inhibitor targeting CDC25 dual specificity phosphatases and displaying in vitro efficacy against melanoma cells.
    Capasso A; Cerchia C; Di Giovanni C; Granato G; Albano F; Romano S; De Vendittis E; Ruocco MR; Lavecchia A
    Oncotarget; 2015 Nov; 6(37):40202-22. PubMed ID: 26474275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiproliferative effect of natural tetrasulfides in human breast cancer cells is mediated through the inhibition of the cell division cycle 25 phosphatases.
    Viry E; Anwar A; Kirsch G; Jacob C; Diederich M; Bagrel D
    Int J Oncol; 2011 Apr; 38(4):1103-11. PubMed ID: 21253673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of CDC25B phosphatase through disruption of protein-protein interaction.
    Lund G; Dudkin S; Borkin D; Ni W; Grembecka J; Cierpicki T
    ACS Chem Biol; 2015 Feb; 10(2):390-4. PubMed ID: 25423142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery and structural optimization of pyrazole derivatives as novel inhibitors of Cdc25B.
    Chen HJ; Liu Y; Wang LN; Shen Q; Li J; Nan FJ
    Bioorg Med Chem Lett; 2010 May; 20(9):2876-9. PubMed ID: 20363629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of highly potent and selective Cdc25 protein phosphatases inhibitors from miniaturization click-chemistry-based combinatorial libraries.
    Jing L; Wu G; Hao X; Olotu FA; Kang D; Chen CH; Lee KH; Soliman MES; Liu X; Song Y; Zhan P
    Eur J Med Chem; 2019 Dec; 183():111696. PubMed ID: 31541869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25.
    Lazo JS; Aslan DC; Southwick EC; Cooley KA; Ducruet AP; Joo B; Vogt A; Wipf P
    J Med Chem; 2001 Nov; 44(24):4042-9. PubMed ID: 11708908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catalytic and chemical competence of regulation of cdc25 phosphatase by oxidation/reduction.
    Sohn J; Rudolph J
    Biochemistry; 2003 Sep; 42(34):10060-70. PubMed ID: 12939134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery and characterization of novel imidazopyridine derivative CHEQ-2 as a potent CDC25 inhibitor and promising anticancer drug candidate.
    Song Y; Lin X; Kang D; Li X; Zhan P; Liu X; Zhang Q
    Eur J Med Chem; 2014 Jul; 82():293-307. PubMed ID: 24922544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cdc25 phosphatases: structure, specificity, and mechanism.
    Rudolph J
    Biochemistry; 2007 Mar; 46(12):3595-604. PubMed ID: 17328562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-based development of novel triazoles and related thiazolotriazoles as anticancer agents and Cdc25A/B phosphatase inhibitors. Synthesis, in vitro biological evaluation, molecular docking and in silico ADME-T studies.
    Rostom SAF; Badr MH; Abd El Razik HA; Ashour HMA
    Eur J Med Chem; 2017 Oct; 139():263-279. PubMed ID: 28803043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological evaluation of caulibugulones A-E.
    Wipf P; Joo B; Nguyen T; Lazo JS
    Org Biomol Chem; 2004 Aug; 2(15):2173-4. PubMed ID: 15280951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a potent and selective pharmacophore for Cdc25 dual specificity phosphatase inhibitors.
    Lazo JS; Nemoto K; Pestell KE; Cooley K; Southwick EC; Mitchell DA; Furey W; Gussio R; Zaharevitz DW; Joo B; Wipf P
    Mol Pharmacol; 2002 Apr; 61(4):720-8. PubMed ID: 11901209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of novel PRL-3 inhibitors based on the structure-based virtual screening.
    Park H; Jung SK; Jeong DG; Ryu SE; Kim SJ
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2250-5. PubMed ID: 18358718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of a tetronic acid library focused on inhibitors of tyrosine and dual-specificity protein phosphatases and its evaluation regarding VHR and cdc25B inhibition.
    Sodeoka M; Sampe R; Kojima S; Baba Y; Usui T; Ueda K; Osada H
    J Med Chem; 2001 Sep; 44(20):3216-22. PubMed ID: 11563920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of potent and selective Cdc25 phosphatase inhibitors via rapid assembly and in situ screening of Quinonoid-focused libraries.
    Tao Y; Hao X; Jing L; Sun L; Cherukupalli S; Liu S; Wu G; Xu S; Zhang X; Shi X; Song Y; Liu X; Zhan P
    Bioorg Chem; 2021 Oct; 115():105254. PubMed ID: 34426152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2,4-Dihydroxychalcone derivatives as novel potent cell division cycle 25B phosphatase inhibitors and protein tyrosine phosphatase 1B inhibitors.
    Xie C; Sun Y; Pan CY; Tang LM; Guan LP
    Pharmazie; 2014 Apr; 69(4):257-62. PubMed ID: 24791588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanosecond molecular dynamics simulations of Cdc25B and its complex with a 1,4-naphthoquinone inhibitor: implications for rational inhibitor design.
    Ko S; Lee W; Lee S; Park H
    J Mol Graph Model; 2008 Aug; 27(1):13-9. PubMed ID: 18359256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CDC25A and B dual-specificity phosphatase inhibitors: potential agents for cancer therapy.
    Lavecchia A; Di Giovanni C; Novellino E
    Curr Med Chem; 2009; 16(15):1831-49. PubMed ID: 19442149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.